Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
Strides Pharma Global secures approval for Fluoxetine Tablets, completing its portfolio for the US market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Pharma Global
Strides gets USFDA approval for Potassium Chloride for Oral Solution
Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia
Strides gets USFDA nod for Oxybutynin Chloride Tablets
They are used to treat overactive bladder and urinary conditions
Strides receives USFDA approval for Ethacrynic Acid Tablets
It is used to treat oedema (excess fluid held in body tissues) in adults and children
Strides gets USFDA approval for butalbital, acetaminophen and caffeine tablets
They are indicated for the relief of the symptom complex of tension or muscle contraction headache
Strides gets USFDA approval for Ursodiol tablets
Product to be launched immediately and marketed by Strides Pharma in the US market
Strides receives US FDA approval for Tetracycline Hydrochloride Capsules
The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc (previously Heritage…
Strides announces final closure of Arrow transaction
According to the statement filed by the company with BSE, all proceeds net of transaction cost will be used to pare down debt
Strides inks agreements with Aspen Pharmacare Holdings
To acquire a generic pharma business in Australia and related assets from Aspen for approximately A$380 million
Singapore EDB grants International headquarter status to Strides Pharma Global
Strides Arcolab announced that its wholly owned subsidiary Strides Pharma Global Pte. Ltd. Singapore (Strides Pharma Global) has…